Recent News

• 12.31.2024 - Galera Therapeutics completes acquisition of Nova Pharmaceuticals

Recent Filings

• 01.24.2025 - DEF 14A Other definitive proxy statements
• 01.14.2025 - D Notice of Exempt Offering of Securities
• 01.02.2025 - 4 Statement of changes in beneficial ownership of securities
• 01.02.2025 - 3 Initial statement of beneficial ownership of securities
• 12.31.2024 - 8-K Current report
• 12.31.2024 - EX-99.1 EX-99.1
• 12.13.2024 - 10-Q Quarterly report [Sections 13 or 15(d)]
• 11.15.2024 - NT 10-Q Notification of inability to timely file Form 10-Q or 10-QSB
• 09.06.2024 - 25-NSE Notification filed by national security exchange to report the removal from listing and registration of matured, redeemed or retired securities
• 08.23.2024 - PRE 14A Other preliminary proxy statements